WASHINGTON, D.C.– The U.S. National Security Commission on Emerging Biotechnology issued its first report since its creation through the National Defense Authorization Act of FY2022. The bipartisan ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine, as global R&D investment approaches $360 billion ...

Affinity Technologies (NASDAQ:BIAF) announced on March 10, 2026, the launch of a large longitudinal clinical study involving 2,000 patients to evaluate the performance of its CyPath® Lung technology ...

The National Security Commission on Emerging Biotechnology (NSCEB) delivered its major report and action plan to Congress in early April with a blunt message: the world is entering a new age driven by ...

Our Food & Beverage and FDA teams explore a plan from a trio of federal agencies that seeks to implement regulatory reform and update the Coordinated Framework for the Regulation of Biotechnology. The ...

Using biological agents as weapons is illegal, but an organism that scientists lawfully use for genuine research could be repurposed for an attack. Therefore, what is banned depends on what an actor ...

The comprehensive report from the bipartisan National Security Commission on Emerging Biotechnology (NSCEB) delivers a “sobering, even frightening,” conclusion: that China is quickly ascending to ...

By Edward Dankwah, GNA Accra, March 11, GNA – The Council for Scientific and Industrial Research – Savanna Agricultural Research Institute (CSIR-SARI) has engaged stakeholders in Ghana’s biotechnology ...

To address this rapidly changing technical environment, a standard playbook should be used to gather domain-specific experts in the science and related technology along with interested stakeholders by ...

Even during this tense election year, bipartisan coalitions are taking steps to enhance national security, protect American-owned intellectual property and secure the country’s supply chain by ...